NATCO PHARMA
Back to Income Statement
|
NATCO PHARMA Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹1,388 Cr | ₹715 Cr | ₹170 Cr | ₹441 Cr | ₹461 Cr |
What is the latest Consolidated Net Profit of NATCO PHARMA ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹1,388 Cr |
Mar2023 | ₹715 Cr |
Mar2022 | ₹170 Cr |
Mar2021 | ₹441 Cr |
Mar2020 | ₹461 Cr |
How is Consolidated Net Profit of NATCO PHARMA Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹1,388 Cr | 94.09 | |
Mar2023 | ₹715 Cr | 320.76 | |
Mar2022 | ₹170 Cr | -61.44 | |
Mar2021 | ₹441 Cr | -4.32 | |
Mar2020 | ₹461 Cr | - |
Compare Consolidated Net Profit of peers of NATCO PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATCO PHARMA | ₹22,124.2 Cr | 6.4% | -6.9% | 35.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹423,974.0 Cr | 1.3% | -4.7% | 22.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹161,729.0 Cr | 6.3% | 3.3% | 59.2% | Stock Analytics | |
CIPLA | ₹116,999.0 Cr | -0.7% | -3.3% | 2.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,771.0 Cr | 2.1% | -9.7% | -0.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,951.9 Cr | 2.1% | -2.8% | 26.4% | Stock Analytics |
NATCO PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATCO PHARMA | 6.4% |
-6.9% |
35.3% |
SENSEX | 2.7% |
0.8% |
9.7% |
You may also like the below Video Courses